<DOC>
	<DOC>NCT02617043</DOC>
	<brief_summary>The study was designed to evaluate the feasibility and safety of hypofractionated whole-breast irradiation with simultaneously integrated boost for early-stage breast cancer after breast conserving surgery in Chinese population.</brief_summary>
	<brief_title>Hypofractionated Whole-breast Irradiation With Simultaneously Integrated Boost For Early-Stage Breast Cancer After Breast-conserving Surgery</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Female 1860 years old Treated with breast conversing surgery and sentinel lymph node biopsy or axillary lymph node dissection Pathologically confirmed invasive breast cancer A pathological T12N0M0 tumor Tumor bed is labeled with Titanium clips Negative surgical margins Written informed consent. KPSï¼œ70 Treated with neoadjuvant chemotherapy Sentinel lymph nodes only containing isolated tumour cells (&lt;0.2 mm) With severe comorbidity Previous breast cancer or other malignant tumor history Previous radiotherapy for breast or thorax Medical contraindication for radiotherapy Pregnant or nursing</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>breast cancer</keyword>
	<keyword>hypofractionated whole breast irradiation</keyword>
</DOC>